Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
An investigational aromatherapy intervention evaluated by Indiana University for the management of symptom burden in patients undergoing hematopoietic stem cell transplantation (HSCT). The intervention utilizes hydrogel adhesive patches infused with specific essential oils—peppermint (or mandarin for sensitive patients) to address chemotherapy-induced nausea, vomiting, and retching (CINVR), and lavender to address anxiety. Manufactured by Wyndmere Naturals, Inc., these patches provide a hypoallergenic, occlusive barrier that allows for the inhalation of aromatic compounds without direct skin contact with the oils. In a randomized, controlled Phase 2 trial involving 92 inpatients, the intervention was found to be safe and associated with high patient satisfaction, although it did not achieve statistically significant improvements in symptom scores compared to a non-scented placebo patch.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on essential oils-Indiana University.